Pre-transplant AFP is independently associated with post‐transplant HCC recurrence survival, suggesting that elevated levels reflect increased tumor aggressiveness that is present even with recurrent disease [40–41]. The gene discussed is AFP; the disease is hepatocellular carcinoma.